Drug Trial Radar · NCT01537081
Safety and Efficacy of Mucinex and IR Guaifenesin the Treatment of Symptoms of Acute Upper Respiratory Tract Infections
Last checked: Nov 20, 2026Latest source record: Nov 14, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,810
Actual
Start
Sep 2011
Primary completion
Mar 2012
Study completion Jul 2012
Sponsor
- Lead sponsor
- Reckitt Benckiser LLCIndustry
- Sponsor type
- Industry
- First posted
- Feb 22, 2012
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study is designed to meet regulatory requirement outside the US. The dosing regimen and assessments timepoints were dictated by immediate release (IR) guaifenesin (GGE) and do not match approved Mucinex labeling in the U.S. The purpose of this study is to determine whether Mucinex is effective and non-inferior as compared to placebo and immediate release guaifenesin in the treatment of symptoms of acute upper respiratory infections. This design was required based on EU regulatory guidance.
Conditions
- Acute Upper Respiratory Tract Infection
Interventions
MucinexDrug
Mucinex combines immediate-release (IR) and modified-release guaifenesin in a bilayer tablet. Each tablet was 600 mg of guaifenesin and taken by mouth with a full glass of water.
Immediate-release GuaifenesinDrug
Each tablet was 200 mg of immediate-release (IR) guaifenesin and taken by mouth with a full glass of water.
PlaceboDrug
Placebo tablets in two formulations to match either Mucinex or IR guaifenesin taken by mouth with a full glass of water
Primary outcomes
What the sponsor says the trial is designed to measure.
- Summary Scores on the SUM8 Daily Cough and Phlegm Diary Card On the Morning of Day 4Time frame: Day 4
- Summary Scores on the SUM8 Daily Cough and Phlegm Diary Card On the Morning of Day 5Time frame: Day 5
Locations
43 sites in 1 country. Site status is shown where the registry gives one.
Reckitt Benckiser Study Site
Hoover, Alabama
Reckitt Benckiser Study Site
Bell Gardens, California
Reckitt Benckiser Study Site
Harbor City, California
Reckitt Benckiser Study Site
Long Beach, California
Reckitt Benckiser Study Site
Sacramento, California
Reckitt Benckiser Study Site
San Francisco, California
Reckitt Benckiser Study Site
San Luis Obispo, California
Reckitt Benckiser Study Site
Colorado Springs, Colorado
Reckitt Benckiser Study Site
Denver, Colorado
Reckitt Benckiser Study Site
Daytona Beach, Florida
Reckitt Benckiser Study Site
Edgewater, Florida
Reckitt Benckiser Study Site
Largo, Florida
Reckitt Benckiser Study Site
Chicago, Illinois
Reckitt Benckiser Study Site
Normal, Illinois
Reckitt Benckiser Study Site
Wichita, Kansas
Reckitt Benckiser Study Site
Lexington, Kentucky
Reckitt Benckiser Study Site
Metairie, Louisiana
Reckitt Benckiser Study Site
New Orleans, Louisiana
Reckitt Benckiser Study Site
Brighton, Massachusetts
Reckitt Benckiser Study Site
Fall River, Massachusetts
Reckitt Benckiser Study Site
Bellevue, Nebraska
Reckitt Benckiser Study Site
Omaha, Nebraska
Reckitt Benckiser Study Site
Omaha, Nebraska
Reckitt Benckiser Study Site
Las Vegas, Nevada
Reckitt Benckiser Study Site
Las Vegas, Nevada
Reckitt Benckiser Study Site
Rochester, New York
Reckitt Benckiser Study Site
Raleigh, North Carolina
Reckitt Benckiser Study Site
Cincinnati, Ohio
Reckitt Benckiser Study Site
Middleburg Heights, Ohio
Reckitt Benckiser Study Site
Warwick, Rhode Island
Reckitt Benckiser Study Site
Greer, South Carolina
Reckitt Benckiser Study Site
Dakota Dunes, South Dakota
Reckitt Benckiser Study Site
Franklin, Tennessee
Reckitt Benckiser Study Site
Jackson, Tennessee
Reckitt Benckiser Study Site
New Tazewell, Tennessee
Reckitt Benckiser Study Site
Smyrna, Tennessee
Reckitt Benckiser Study Site
Austin, Texas
Reckitt Benckiser Study Site
Carrollton, Texas
Reckitt Benckiser Study Site
Forth Worth, Texas
Reckitt Benckiser Study Site
San Angelo, Texas
Showing 40 of 43 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.